Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial-Reference-Cited by-同舟云学术

Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial

Published:2020-10-10 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Thianboonsong Thianthong¹,Kanokrungsee Silada¹^ORCID,Paichitrojjana Anon¹,Udompataikul Montree¹,Kamanamool Nanticha²,Rojhirunsakool Salinee¹^ORCID

Affiliation:

1. Skin Center Srinakharinwirot University Bangkok Thailand

2. Department of Preventive and Social Medicine Srinakharinwirot University Bangkok Thailand

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14354

Reference21 articles.

1. Prevalence and disease burden of hyperhidrosis in the adult population;Augustin M;Dermatology,2013

2. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: From questionnaire analysis

3. Incidence and Prevalence of Hyperhidrosis

4. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work‐up;Nawrocki S;J Am Acad Dermatol,2019

5. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Topical Anticholinergics in the Management of Focal Hyperhidrosis in Adults and Children. A Narrative Review;Actas Dermo-Sifiliográficas;2024-04

2. Tratamiento farmacológico de la hiperhidrosis primaria;Piel;2023-10

3. Anticolinérgicos tópicos en el manejo de la hiperhidrosis focal en adultos y niños. Una revisión narrativa;Actas Dermo-Sifiliográficas;2023-09

4. Treat hyperhidrosis with topical therapies first, then dermatological or systemic therapies;Drugs & Therapy Perspectives;2023-05-20

5. Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial;Journal of the European Academy of Dermatology and Venereology;2023-01-31